VERU INC (VERU:NASDAQ)
$2.44 -0.06 (-2.4%)
Analysed VERU INC (VERU:NASDAQ) News Sources
Earnings call transcript: Veru Inc Q2 2026 shows improved financials
01-06-2026
stocktwits.com
Veru Teams Up With Novo Nordisk for Obesity Combination Therapy Trial (VERU)
04-06-2026
advfn.com
This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection?
04-06-2026
stocktwits.com
Novo Nordisk Tests Wegovy Combinations In Older Adults With Veru Trial
05-06-2026
yahoo.com
Veru And 2 Other Intriguing Penny Stocks To Watch
05-06-2026
yahoo.com
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
07-07-2026
yahoo.com
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
27-07-2026
yahoo.com
Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
30-07-2026
yahoo.com
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
04-08-2026
yahoo.com
Veru (VERU) Q3 2026 Earnings Call Transcript
17-08-2026
fool.com
What is the current price of VERU INC (VERU:NASDAQ)?
The current price of VERU INC (VERU:NASDAQ) is $2.44.
VERU INC (VERU:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERU INC (VERU:NASDAQ) since the previous trading day is $-0.06.
VERU INC (VERU:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERU INC (VERU:NASDAQ) since the previous trading day is -2.4%.
What is the most recent average sentiment score for VERU INC (VERU:NASDAQ)?
The most recent average sentiment score for VERU INC (VERU:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for VERU INC (VERU:NASDAQ)?
The most recent sentiment for VERU INC (VERU:NASDAQ) is .
SEC-8K** Filing Available For VERU INC (VERU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.